Ninlib Capsules (Nilotinib): Product Description, Strengths, Uses, Benefits and Side Effects in Sing
Description
Ninlib Capsules contain Nilotinib, a tyrosine kinase inhibitor (TKI) used in the treatment of certain forms of Philadelphia chromosome-positive chronic myeloid leukaemia (Ph+ CML). This targeted cancer medicine works by inhibiting the BCR-ABL tyrosine kinase, an abnormal protein that contributes to the uncontrolled growth of leukaemia cells.
Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical product information for healthcare professionals, distributors and international pharmaceutical buyers. Patients and healthcare professionals in Singapore should verify the product's registration status, approved indications and availability before considering its use.
Ninlib Capsules Strengths
Nilotinib capsules are available in several strengths in Singapore's medicine formulary, including:
Nilotinib 150 mg capsules
Nilotinib 200 mg capsules
Important: These are recognised nilotinib strengths, not confirmation that every strength is available under the Ninlib brand. Please verify Ninlib's actual product specifications and approved pack details with Cordium Pharmaceuticals Pvt Ltd before publication or ordering.
Uses and Benefits of Nilotinib Capsules
Nilotinib may be prescribed for eligible patients with specific types of Ph+ CML, depending on age, disease phase, previous treatment and the applicable product approval.
Potential therapeutic benefits include:
Targeted treatment: Inhibits the abnormal BCR-ABL protein associated with Ph+ CML.
Disease control: Helps reduce the activity and growth of leukaemia cells in appropriately selected patients.
Molecular response: Treatment may help patients achieve a deeper molecular response, assessed through regular blood and molecular testing.
Individualised treatment: Oncologists select the appropriate treatment regimen based on clinical history, laboratory results and treatment response.
Nilotinib is not suitable for every patient and must be used under specialist medical supervision. It is not a general-purpose medicine or a substitute for other cancer treatments without medical advice.
Possible Side Effects of Ninlib (Nilotinib)
Nilotinib may cause side effects, and patients should discuss their individual risks with their treating oncologist.
Commonly reported side effects include:
Headache and fatigue
Nausea and abdominal discomfort
Rash and itching
Constipation or diarrhoea
Changes in blood cell counts
Changes in liver or pancreatic enzyme levels
Serious safety risks: Nilotinib can prolong the QT interval, potentially causing dangerous heart rhythm disturbances. It may also increase the risk of cardiovascular events, pancreatitis and abnormalities in blood glucose or lipid levels.
Seek urgent medical attention for fainting, an irregular heartbeat, chest pain, severe abdominal pain or other serious symptoms. Regular ECGs and blood tests may be required during treatment.
Frequently Asked Questions (FAQs)
1. What is Ninlib used for?
Ninlib contains nilotinib, a targeted medicine intended for certain patients with Philadelphia chromosome-positive chronic myeloid leukaemia, subject to the product's approved indications.
2. Is Ninlib available in Singapore?
Availability depends on the product's registration and supply arrangements. Check the Singapore Health Sciences Authority (HSA) register or consult a licensed healthcare professional before purchasing.
3. What strengths of nilotinib capsules are available?
Nilotinib capsule strengths listed in Singapore's National Drug Formulary include 50 mg, 150 mg and 200 mg. Confirm the strengths specifically supplied under the Ninlib brand.
4. Can I take Ninlib without a prescription?
No. Nilotinib requires medical supervision and should only be used as prescribed by a qualified healthcare professional.
5. How can I obtain product information from Cordium Pharmaceuticals?
Healthcare professionals and pharmaceutical buyers may contact Cordium Pharmaceuticals Pvt Ltd to request verified product specifications, packaging details and applicable regulatory documentation.
Contact Cordium Pharmaceuticals Pvt Ltd
For verified information about Ninlib Capsules (Nilotinib), including product strengths, documentation and international supply enquiries, contact Cordium Pharmaceuticals Pvt Ltd directly.
Medical disclaimer: This page is for general informational purposes only and does not replace professional medical advice. Product registration, indications and supply in Singapore must be independently verified before marketing or distribution.







